Clinical Trials
6 trialsNCT03501979 2025-08-29
Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
University of Alabama at Birmingham
Phase 2 Terminated
NCT05414123 2023-10-16
FORESEE
Biocept, Inc.
Terminated
NCT03711422 2022-06-14
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
National Cancer Centre, Singapore
Phase 1 Terminated
NCT01596127 2018-05-24
Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT00512460 2016-05-16
RTA 744 Injection in Patients With Leptomeningeal Disease
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00515788 2012-03-12
DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
M.D. Anderson Cancer Center
Phase 1 Terminated